Equity Overview
Price & Market Data
Price: $0.28
Daily Change: $0.00 / 0.00%
Range: $0.28 - $0.48
Market Cap: $143,638
Volume: 10,603
Performance Metrics
1 Week: 12.50%
1 Month: 462.5%
3 Months: -99.69%
6 Months: -99.91%
1 Year: -100.00%
YTD: -99.75%
Company Details
Employees: 41
Sector: Health technology
Industry: Biotechnology
Country: United Kingdom
Details
TC Biopharm (Holdings) Plc, a clinical-stage biopharmaceutical company, focuses on the development of immunotherapy products based on its allogeneic gamma delta T cell platform. Its product pipeline includes OmnImmune, an allogeneic unmodified gamma-delta T cell therapy product under Phase 2/3 trails for the treatment of acute myeloid leukemia; and ImmuniStim, an unmodified cell therapy to treat viral infections as well as cancers. The company was founded in 2013 and is headquartered in Motherwell, the United Kingdom.